Deals Rumor Mill: Teva, ConvaTec, Abraaj

By Matthew Perlman ( May 13, 2016, 6:16 PM EDT) -- Mylan NV and Novartis AG are among possible suitors exploring a purchase of Teva Pharmaceutical Industries Ltd. 's portfolio of drugs in the U. K. , Ireland and Iceland, a Bloomberg report said Friday. Teva could bring in as much as $2 billion for the businesses, which are also seeing interest from private equity investors Apollo Global Management LLC and Cinven Ltd. , according to the report. The company is working with Greenhill & Co. to find a buyer, in order to win regulatory approval for its planned $40. 5 billion acquisition of Allergan PLC's generics business, the report said. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login